Literature DB >> 19221260

Risk factors for the development of ocular complications of Stevens-Johnson syndrome and toxic epidermal necrolysis.

Julie Gueudry1, Jean-Claude Roujeau, Michel Binaghi, Gisèle Soubrane, Marc Muraine.   

Abstract

OBJECTIVES: To describe the acute and late ocular manifestations of toxic epidermal necrosis (TEN), Stevens-Johnson syndrome (SJS), and overlap syndrome and to identify predictors for the development of ocular complications.
DESIGN: Retrospective cohort study.
SETTING: A single referral unit in a university hospital. PATIENTS: The study included 159 patients (mean [SD] age, 49.9 [19.8] years) with TEN and SJS during an 8-year period. Forty-nine patients were contacted at least 15 months after hospital discharge. MAIN OUTCOME MEASURES: Records were reviewed for demographics, cause of the condition, and severity of ocular involvement. The patients were contacted to assess late ocular complications.
RESULTS: A total of 117 patients (74%) had acute ocular involvement, which was mild in 58%, moderate in 8%, and severe in 8%. Patients with TEN had more frequent (odds ratio [OR], 2.7; 95% confidence interval [CI], 1.06-6.90; P = .05) but not more severe (OR, 0.95; 95% CI, 0.20-4.5; P = .99) acute ocular involvement. Forty-nine patients were contacted at least 15 months after hospital discharge, and 63% had late ocular complications. Dry eye syndrome was the most common. The mean (SD) Ocular Surface Disease Index score was 32.9 (30.3) (range, 0-97.5). The severity of the acute ocular disease was found to be the only significant risk factor of late complications (P = .002), even though 5 patients without acute ocular involvement developed dry eye syndrome.
CONCLUSIONS: Ocular involvement is common in patients with SJS and TEN. Late complications are more frequent in patients with severe initial eye involvement but may also develop in patients without patent initial ocular symptoms.

Entities:  

Mesh:

Year:  2009        PMID: 19221260     DOI: 10.1001/archdermatol.2009.540

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  33 in total

Review 1.  Severe Cutaneous Adverse Drug Reactions: Presentation, Risk Factors, and Management.

Authors:  S Shahzad Mustafa; David Ostrov; Daniel Yerly
Journal:  Curr Allergy Asthma Rep       Date:  2018-03-24       Impact factor: 4.806

2.  Toxic epidermal necrolysis with ocular involvement following vaccination for hemorrhagic fever with renal syndrome.

Authors:  Young Hoon Hwang; Myung Seung Kang; Kyung O Lim; Sang Mok Lee
Journal:  Yonsei Med J       Date:  2012-01       Impact factor: 2.759

3.  A cross-sectional comparative study on chronic ocular manifestations of Stevens-Johnson syndrome and toxic epidermal necrolysis in Chinese eyes: a 15-year case series.

Authors:  Loraine L W Chow; Alex L K Ng; Sharon S W Chow; Bonnie N K Choy; Kendrick C Shih; Ian Y H Wong; Johnny C Y Chan; Jimmy S M Lai
Journal:  Int Ophthalmol       Date:  2017-05-25       Impact factor: 2.031

4.  Sutureless amniotic membrane transplantation with cyanoacrylate glue for acute Stevens-Johnson syndrome/toxic epidermal necrolysis.

Authors:  Swapna S Shanbhag; James Chodosh; Hajirah N Saeed
Journal:  Ocul Surf       Date:  2019-03-11       Impact factor: 5.033

5.  The cost-effectiveness of HLA-B*5801 screening to guide initial urate-lowering therapy for gout in the United States.

Authors:  Eric Jutkowitz; Maureen Dubreuil; Na Lu; Karen M Kuntz; Hyon K Choi
Journal:  Semin Arthritis Rheum       Date:  2016-11-01       Impact factor: 5.532

6.  Epidemiology of ophthalmologic disease associated with erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis in hospitalized children in the United States.

Authors:  Jacqueline F Moreau; Robert S Watson; Mary E Hartman; Walter T Linde-Zwirble; Laura K Ferris
Journal:  Pediatr Dermatol       Date:  2013-05-16       Impact factor: 1.588

7.  Long-term outcomes of amniotic membrane treatment in acute Stevens-Johnson syndrome/toxic epidermal necrolysis.

Authors:  Swapna S Shanbhag; Leangelo Hall; James Chodosh; Hajirah N Saeed
Journal:  Ocul Surf       Date:  2020-03-19       Impact factor: 5.033

Review 8.  SJS/TEN 2017: Building Multidisciplinary Networks to Drive Science and Translation.

Authors:  Katie D White; Riichiro Abe; Michael Ardern-Jones; Thomas Beachkofsky; Charles Bouchard; Bruce Carleton; James Chodosh; Ricardo Cibotti; Robert Davis; Joshua C Denny; Roni P Dodiuk-Gad; Elizabeth N Ergen; Jennifer L Goldman; James H Holmes; Shuen-Iu Hung; Mario E Lacouture; Rannakoe J Lehloenya; Simon Mallal; Teri A Manolio; Robert G Micheletti; Caroline M Mitchell; Maja Mockenhaupt; David A Ostrov; Rebecca Pavlos; Munir Pirmohamed; Elena Pope; Alec Redwood; Misha Rosenbach; Michael D Rosenblum; Jean-Claude Roujeau; Arturo P Saavedra; Hajirah N Saeed; Jeffery P Struewing; Hirohiko Sueki; Chonlaphat Sukasem; Cynthia Sung; Jason A Trubiano; Jessica Weintraub; Lisa M Wheatley; Kristina B Williams; Brandon Worley; Wen-Hung Chung; Neil H Shear; Elizabeth J Phillips
Journal:  J Allergy Clin Immunol Pract       Date:  2018 Jan - Feb

Review 9.  Severe Delayed Cutaneous and Systemic Reactions to Drugs: A Global Perspective on the Science and Art of Current Practice.

Authors:  Jonathan Grant Peter; Rannakoe Lehloenya; Sipho Dlamini; Kimberly Risma; Katie D White; Katherine C Konvinse; Elizabeth J Phillips
Journal:  J Allergy Clin Immunol Pract       Date:  2017 May - Jun

10.  Clinical Aspects of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis With Severe Ocular Complications in Taiwan.

Authors:  David Hui-Kang Ma; Tsung-Ying Tsai; Li-Yen Pan; Shin-Yi Chen; Ching-Hsi Hsiao; Lung-Kun Yeh; Hsin-Yuan Tan; Chun-Wei Lu; Chun-Bing Chen; Wen-Hung Chung
Journal:  Front Med (Lausanne)       Date:  2021-05-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.